Evidence map›Paper›PMID 37204748›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2023

The TEG 5000 System: System Description and Protocol for Measurements.

Oksana Volod, Alice Runge

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07145281 (Comparing the Effects of Sublingual Estradiol Treatment Versus Oral Estradiol With Cyproterone Acetate), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07145281 nacompletednot on this map

Comparing the Effects of Sublingual Estradiol Treatment Versus Oral Estradiol With Cyproterone Acetate (CPA) Treatment on The Coagulation System in Transgender Women: A Prospective, Controlled Cohort Study

TypeinterventionalSponsorTel-Aviv Sourasky Medical CenterRan2022 to 2024Enrolled30ConditionsGender Dysphoria, Adult, Blood Coagulation, Coagulation Factors, Transgender Persons, M01.777.500ArmsEstradiol (E2), Cyproterone Acetate (Androcur, BAY94-8367)
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Innovative Diagnostic Solutions in Hemostasis.Diagnostics (Basel, Switzerland) · 2024
    Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Oksana VolodCedars-Sinai Medical Center, Los Angeles, CA, USA. Oksana.Volod@cshs.org.
Alice RungeCedars-Sinai Medical Center, Los Angeles, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The thromboelastograph (TEG) has undergone several modifications, but the concept on which the original TEG was based (cup and pin technology) remained up to the TEG 5000 analyzer (Haemonetics, Braintree, MA). In a previous chapter, we reviewed the advantages and limitations of TEG 5000 as well as factors that affect TEG and which must be considered when interpreting tracings. In the present chapter, we provide a description of the TEG 5000 principle and its operation protocol.

Indexed as

TechnologyThrombelastographyReview Literature as TopicThromboelastographyViscoelastic testing

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.